| 2009 | The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases | 하헌주 | Review |
| 2013 | The role of plasminogen activator inhibitor-1 in the regulation of adipocyte function | 정인지 | Master's Thesis |
| 2020 | The role of Src family kinases in chronic kidney disease | DOROTEA, DEBRA | Doctoral Thesis |
| 2013 | The selective A3AR antagonist LJ-1888 ameliorates UUO-induced tubulointerstitial fibrosis | 정낙신; 하헌주; 이정현 | Article |
| 2011 | TM5275 and TM5441, novel inhibitors of plasminogen activator inhibitor-1, prevent renal injury in streptozotocin-induced diabetic mice | 정보영 | Master's Thesis |
| 2017 | TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease | 하헌주 | Article |
| 2020 | Urinary Metabolomic Profiling in Streptozotocin-Induced Diabetic Mice after Treatment with Losartan | 하헌주; 황금숙 | Article |
| 2019 | Urinary myo-inositol is associated with the clinical outcome in focal segmental glomerulosclerosis | 하헌주; 황금숙 | Article |
| 2013 | Where are we now in diabetic research? | 하헌주 | Review |
| 2009 | Wnt/β-catenin signaling: A novel target for therapeutic intervention of fibrotic kidney disease | 하헌주 | Review |
| 2005 | 방사성 요오드 치료 전 혈중 thyroglobulin과 치료 후 I-131 uptake 및 thyroglobulin 변화와의 관계 | 김지나 | Master's Thesis |
